| 000 | 01309 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515203215.0 | ||
| 264 | 0 | _c20100315 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1470-8752 | ||
| 024 | 7 |
_a10.1042/BST0380281 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmallwood, Dawn T | |
| 245 | 0 | 0 |
_aLamin A-linked progerias: is farnesylation the be all and end all? _h[electronic resource] |
| 260 |
_bBiochemical Society transactions _cFeb 2010 |
||
| 300 |
_a281-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aFarnesyltranstransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLamin Type A _xchemistry |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNuclear Envelope _xmetabolism |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPrenylation |
| 650 | 0 | 4 |
_aProgeria _xdrug therapy |
| 700 | 1 | _aShackleton, Sue | |
| 773 | 0 |
_tBiochemical Society transactions _gvol. 38 _gno. Pt 1 _gp. 281-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/BST0380281 _zAvailable from publisher's website |
| 999 |
_c19451703 _d19451703 |
||